Hind Berrahmoune
Publications by Year
Research Areas
Regulation of Appetite and Obesity, Adipokines, Inflammation, and Metabolic Diseases, Pancreatic function and diabetes, Computational Drug Discovery Methods, Pharmacogenetics and Drug Metabolism
Most-Cited Works
- → Peripheral blood mononuclear cells (PBMCs): a possible model for studying cardiovascular biology systems(2007)61 cited
- → Biological Determinants of and Reference Values for Plasma Interleukin-8, Monocyte Chemoattractant Protein-1, Epidermal Growth Factor, and Vascular Endothelial Growth Factor: Results from the STANISLAS Cohort(2006)53 cited
- → The Neuropeptide 26RFa (QRFP) and Its Role in the Regulation of Energy Homeostasis: A Mini-Review(2016)45 cited
- → Genetic Polymorphism ofCYP2C19Gene in the Stanislas Cohort. A link with Inflammation(2008)39 cited
- → Pharmacogenomics and cardiovascular drugs: Need for integrated biological system with phenotypes and proteomic markers(2005)34 cited
- → Heritability for Plasma VEGF Concentration in the Stanislas Family Study(2006)34 cited
- → Hypothalamic Neuropeptide 26RFa Acts as an Incretin to Regulate Glucose Homeostasis(2015)31 cited
- → Pharmacogenomics and drug response in cardiovascular disorders(2004)31 cited
- → Sex‐dependent Associations of Leptin With Metabolic Syndrome–related Variables: The Stanislas Study(2009)30 cited
- → Five-year alterations in BMI are associated with clustering of changes in cardiovascular risk factors in a gender-dependant way: the Stanislas study(2008)29 cited